QPharma, a leader in Medical, Commercial and Compliance Services for the life sciences industry announced the launch of Neolytica, a subsidiary, that will improve healthcare analytics.
QPharma has been a pioneer in the compliance space for 25 years and has achieved tremendous success and traction in recent times in healthcare analytics – specifically with Ti Expert™, the KOL mapping and HCP targeting solution, and NotifyMe™ the KOL/HCP activity alert solution. This is one of the key drivers behind launching Neolytica, which focuses on platforms and solutions using next-generation technologies like NLP, AI, face recognition, and chatbots to amplify the much-required technological advancements in analysis for the healthcare community. This amplification is primarily focused on Medical Affairs/MSL, Market Access, Commercial Marketing and Sales teams’ analytics and insights.
A significant part of QPharma’s growth is the result of its ability to identify gaps in the industry and to solve those gaps with innovative solutions. QPharma’s decision to focus on and invest in data analytics and AI, synergizes well with its expertise in the pharmaceutical industry.
“QPharma’s recent successes have been driven by innovations like Sample Direct-to-Patient, Sentiment Analysis and NotifyMe, which addressed specific gaps during the Covid-19 crisis. By addressing these gaps through innovation, it impressed upon us the impact QPharma could have in the industry, if it focused and invested more on analytics,” said QPharma President and CEO, Patrick Den Boer.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!